Washington Trust Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-500
Closed -$5K 835
2016
Q1
$5K Hold
500
﹤0.01% 643
2015
Q4
$9K Hold
500
﹤0.01% 609
2015
Q3
$7K Hold
500
﹤0.01% 653
2015
Q2
$11K Hold
500
﹤0.01% 655
2015
Q1
$7K Sell
500
-500
-50% -$7.21K ﹤0.01% 706
2014
Q4
$10K Hold
1,000
﹤0.01% 713
2014
Q3
$9K Hold
1,000
﹤0.01% 697
2014
Q2
$10K Hold
1,000
﹤0.01% 733
2014
Q1
$13K Buy
+1,000
New +$14.8K ﹤0.01% 669

Other funds holding HALO

Washington Trust Bank's HALO Position: Q2 2016 in Review

Washington Trust Bank sold out of Halozyme (HALO) in Q2 2016, closing a stake of 500 shares — an estimated $5K sold.

Washington Trust Bank first reported a position in HALO in Q1 2014 and held it in 9 quarters. The position peaked at $13K in Q1 2014. 161 funds tracked by Wall St. Rank hold HALO as of Q2 2016.

  • Washington Trust Bank reported no remaining Halozyme position as of Q2 2016 after selling out during the quarter.
  • Washington Trust Bank sold 500 Halozyme shares in Q2 2016, an estimated $5K.
  • Washington Trust Bank first reported a position in Halozyme in Q1 2014 and held it in 9 quarters.
  • Washington Trust Bank's Halozyme position peaked at $13K in Q1 2014.
  • 161 funds tracked by Wall St. Rank held Halozyme as of Q2 2016.

Based on Washington Trust Bank's 13F filing for Q2 2016, filed 7 Jul 2016.